Skip to main content
Premium Trial:

Request an Annual Quote

CapitalBio to Provide Roche NimbleGen Array Services in China


By Justin Petrone

Chinese genomic services provider CapitalBio has joined the Roche NimbleGen certified service provider program, Roche said last week.

Beijing-based CapitalBio has been certified to offer NimbleGen gene expression, comparative genomic hybridization and copy number variation, and DNA methylation services to Asian customers.

CapitalBio is also the first NimbleGen certified service provider in Asia to implement the MS 200 Microarray Scanner into its array workflow for high-resolution scanning, Roche said. Korea's DNA Link was certified by Roche in October to offer target enrichment services on NimbleGen sequence capture arrays (see BAN 10/20/2009).

Andreas Görtz, vice president of marketing for Roche NimbleGen, said in a statement that the certification positions the Madison, Wis.-based array company for "tremendous future growth in this rapidly developing market."

Junquan Xu, vice president of operations at CapitalBio, in a statement called the certification a "major step forward in our efforts to bring advanced DNA analysis to China." Founded in 2000, CapitalBio employs nearly 400 people and sells its own portfolio of arrays and instrumentation. CapitalBio is also a certified Affymetrix services provider.

Financial details were not discussed.

The Scan

And a Fourth?

A fourth dose of the Pfizer-BioNTech SARS-CoV-2 vaccine in an Israeli study increased antibody levels but did not prevent Omicron variant infections, according to the Financial Times.

For Better Science Software

A virtual institute funded by former Google CEO Eric Schmidt's philanthropy aims to lure software engineers to academia, Science reports.

Recommendation Explanations

The New York Times writes that the US Centers for Disease Control and Prevention is straining to both make and explain decisions based on limited information.

Genome Research Papers on De Novo Mutation Rates, Polyploid Genotyping, Oncogene Epigenomic Translocation

In Genome Research this week: de novo mutations rates in hemoglobin subunits, analysis of variant calling methods for polyploid plants, and more.